Awareness gaps of onchocerciasis in endemic Health district of Kéniéba, Séféto, Dioila, Kati and Selingué in 2021: cross - sectional study in Mali.

The Family Smoking Prevention and Tobacco Control Act (TCA) granted the US Food and Drug Administration the authority to regulate tobacco products, including the requirement for graphic health warnings on cigarette packs.[] As of March 2020, these warnings include both textual and photo-realistic depictions of smoking-related health consequences, that must comprise more than half of the front and rear panels of the package.[] One meta-analysis of experimental studies supports graphic images on cigarette packs as more effective in increasing attention, producing negative pack and smoking attitudes, and increasing intentions to either not start or quit smoking.[] However, their impact may vary based on individual smoking characteristics. For instance, a study by Shadel et al.[] found that graphic warnings influenced purchasing behavior more among smokers with longer latency to their first cigarette after waking. More recent work using graphic warning labels has demonstrated that perceived harms and quit intentions were generally increased by graphic health warnings.[]. In addition, nationally representative cross-sectional data from the 2020 Health Information National Trends Survey indicate that nearly 70% of American adults support the policy[]. This report examines the impact of front-of-package health warnings on cigarette packs preferences and smoking behavior, focusing on: 1) attention to warnings, 2) their influence on pack choice, and 3) their effect on quitting intentions. We hypothesize that: 1) individuals exposed to warnings will show greater attention to the warning labels, 2) individuals will prefer packs without warnings, and 3) exposure to warnings will increase intention to quit. Although the FDA-approved graphic health warnings require labels both on the front and rear panels, this study used a 2-D perspective including only front-of package images. In addition, we focus on immediate responses following a single exposure, acknowledging that real-world regulatory environments involve repeated, unavoidable exposure that may produce different outcomes.